Search Results
Jan 06, 2026, 12:30 ET LMU Names Kathleen Weaver, Ph.D. Executive Vice President and Provost
previously served as interim provost since June 2025."Provost Weaver is uniquely positioned for this moment in LMU's life because she brings a rare combination of scholarly excellence, strategic imagination, and evidence-informed decision-making," said President Thomas Poon, Ph.D. "Her leadership
More news about: Loyola Marymount University
Jan 06, 2026, 10:03 ET Announcing Guanology™ -- PreterNatural™ Skincare Anchored in Guanabana
PreterNatural™ Skincare.At the heart of Guanology™ is the guanabana (soursop), valued for its rare acetogenins, antioxidants and a nutrient-rich vitamin profile. Rather than following trend-driven formulation, Guanology™ creates its formulations around
More news about: Guanology
Jan 06, 2026, 10:00 ET NORD Extends Exclusive CME Partnership with Medlive
National Organization for Rare Disorders has again selected the company as its official Continuing Medical Education (CME) partner. This renewed commitment reflects the organizations' shared mission to expand access to rare disease education, equip clinicians with the tools
More news about: Medlive
Jan 06, 2026, 09:35 ET Locksley Confirms Continuous High Grade Mineralized Silver Corridor at its Mojave Project in California
https://www.locksleyresources.com.au) is focused on critical minerals in the U.S. The company is actively advancing the Mojave Project in California, targeting rare earth elements (REEs) and antimony. Locksley is executing a mine-to-market strategy for antimony, aimed at reestablishing domestic supply chains for
More news about: Locksley Resources
Jan 06, 2026, 09:30 ET Boosalis Properties Represents Tenant in 95,598 Sq Ft Industrial Lease in Springfield, VA
Terminal complex, stands as one of the largest industrial lease commitments in the Northern Virginia market for 2025. The property, recognized for its rare rail-served infrastructure, continues to be a distinctive industrial facility within the region, highlighting the ongoing demand for strategically located
More news about: Boosalis Properties
Jan 06, 2026, 09:15 ET Energy EPC Achieves 365+ Days with Zero OSHA Recordable Incidents
-- TruGrid, a leading engineering, procurement, and construction (EPC) company specializing in energy storage and solar, is celebrating an extremely rare safety milestone that few EPCs ever achieve. The company has released a new safety
More news about: TruGrid
Jan 06, 2026, 09:15 ET Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis
researchers used the technology to uncover new insights on melanoma through analysis of proteomic data. Kasey Couts, PhD, co-director of the CU Center for Rare Melanomas said, "I'm not a programmer, but the software is incredibly user-friendly. I don't need an extensive bioinformatics background to use
More news about: Illumina, Inc.
Jan 06, 2026, 09:00 ET Niron Magnetics and Bimotal Join Forces to Power the Future of Motion
which provides a high-performance solution that eliminates reliance on rare earth materials.This collaboration advances a strategic domestic supply chain for high-performance electric motors, addressing critical dependencies in rare earth materials while supporting U.S. manufacturing capabilities.
More news about: Niron Magnetics
Jan 06, 2026, 09:00 ET Mezzion Pharmaceuticals Appoints Physician-Scientist Ridwan Shabsigh, MD, FACS as President & Chief Operating Officer
FORT LEE, N.J., Jan. 6, 2026 /PRNewswire/ -- Mezzion Pharmaceuticals, Inc. (Mezzion), a late-stage rare disease biopharmaceutical company developing the first potential treatment for people born with single ventricle congenital heart disease (SV-CHD) living
More news about: Mezzion Pharmaceuticals, Inc
Jan 06, 2026, 09:00 ET David Hall Returns to CES With Breakthrough AI-Powered Drone Defense and Sustainable Space Launch Technologies
technologies address urgent, real-world challenges.Industry Legacy + Future Vision: David Hall's presence marks a rare story—an innovator who changed transportation decades ago and is now shaping aerospace and defense.CES Booth Experience: The Future
More news about: Velodyne Space; Hall Lidar Inc.
Jan 06, 2026, 09:00 ET WCG Unveils 2026 Trends and Insights Report: Charting a New Era of Readiness, Innovation, and Human-Centric Clinical Research
report examines the operational and workforce challenges of integrating these modalities, as well as the opportunities for personalized medicine and rare disease innovation.Operational Resilience & Collaboration: Across every trend, the need for resilient, adaptable,
More news about: WCG
Jan 06, 2026, 09:00 ET Vella Bioscience Appoints Industry Innovator Joy Allen-Altimare as President, Accelerating a New Era of Femtech, Hormonal Health, and Science-Led Sexual Wellness
reshaped Vella in meaningful and measurable ways," said Carolyn Wheeler, CEO and Co-Founder of Vella Bioscience. "She brings a rare combination of rigor, creativity, and empathy—grounding our brand in science while elevating our connection to the women we serve. Her background in
More news about: Vella Bioscience
Jan 06, 2026, 09:00 ET BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East
sensitivity as a critical performance metric, investigators sought a liquid biopsy platform capable of reliably detecting targetable alterations that may be rare or difficult to uncover in blood. Prior to selecting Northstar Select, the team evaluated the accuracy of a previously used liquid biopsy assay by comparing
More news about: BillionToOne
Jan 06, 2026, 09:00 ET AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE
a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers"
More news about: Amgen
Jan 06, 2026, 08:30 ET Built In Announces Winners of Its 2026 Best Places to Work Awards Program
become a trusted resource for tech professionals seeking employers that align with their priorities and values. For winning companies, it provides a rare opportunity to promote their employer reputation and connect with hard-to-hire tech talent in an increasingly competitive landscape.The 2026
More news about: Built In
Jan 06, 2026, 08:30 ET HC Capital Partners and Herrmann Family Companies launch "Energy Ranch" a 1,500+ Acre Power and Data Infrastructure Campus in South Texas
landowner it's important we consider ways to minimize negative environmental effects, we believe our approach does that.""Energy Ranch represents a rare opportunity to develop a large-load data campus on land that is already owned, in a location purpose-built for power, water, and scale," said Herb Chambers
More news about: HC Capital Partners
Jan 06, 2026, 08:15 ET Atossa Therapeutics Receives FDA "Study May Proceed" Letter for (Z)-Endoxifen Investigational New Drug Application for Metastatic Breast Cancer
Modulator/Degrader (SERM/D) with demonstrated activity across multiple mechanisms of interest. Atossa is evaluating its potential applications in oncology and rare diseases. The Company's proprietary oral formulation has shown a favorable safety profile and pharmacology distinct from tamoxifen, including ER-targeted
More news about: Atossa Therapeutics Inc
Jan 06, 2026, 08:08 ET Tesoro XP Raises $5.4M Seed Round to Build the First Retail-Funded Rewards Platform for Free-to-Play Games
Cruttenden of Treasury. "Tesoro has built a model that aligns incentives for retailers, publishers, and players in a way we've never seen before. This is the rare kind of category-defining innovation we look for.""Tesoro is redefining how players, publishers, and retailers interact inside and outside the
More news about: Tesoro XP
Jan 06, 2026, 08:03 ET Johnson & Johnson unveils new data showing nipocalimab is the first and only investigational FcRn blocker with potential to reduce systemic lupus erythematosus (SLE) activity in a Phase 2 study
functions. This includes autoantibodies and alloantibodies that underlie multiple conditions across three key segments in the autoantibody space including Rare Autoantibody diseases, Maternal Fetal diseases mediated by maternal alloantibodies and autoantibody-driven Rheumatic diseases.8,9,10,11,12,13,14,15,16
More news about: Johnson & Johnson
Jan 06, 2026, 08:00 ET NORD Extends Exclusive CME Partnership with Medlive
Organization for Rare DisordersFounded in 1983, the National Organization for Rare Disorders (NORD®) is a leading independent, nonpartisan, nonprofit and patient advocacy organization dedicated to improving the health and lives of over 30 million Americans living with rare diseases. In
More news about: National Organization for Rare Disorders (NORD®)
Jan 06, 2026, 08:00 ET Benchmark Wine Announces Record Sales Year
the largest inventory of any rare wine retailer or distributor of these investment-grade well aged wines in the country"."While we strive to provide the largest selection of rare wine and spirits in the country, at the best prices, pay more for perfectly-stored rare wine than auction houses or
More news about: Benchmark Wine Group
Jan 06, 2026, 08:00 ET Stealth BioTherapeutics Provides Commercial and R&D Pipeline Update and Outlines 2026 Strategic Priorities
across our pipeline to address urgent unmet needs in rare and age-related diseases of mitochondrial dysfunction."Commercial Update:FORZINITY is currently commercially available for eligible US patients living with BTHS, a rare, serious and life-threatening mitochondrial disease.
More news about: Stealth BioTherapeutics Inc.
Jan 06, 2026, 08:00 ET Chromatin Bioscience, Mediphage Bioceuticals, and Entos Pharmaceuticals, collaborate on Genetic Medicines Project with support from UKRI Innovate UK and Canadian R&D Funding
treat an unlimited number of genetic diseases. The potential impact of this three-way collaboration on the future of genetic medicines and the lives of rare disease patients is transformative."This collaboration brings together three complementary technologies to address one of the biggest challenges
More news about: CHROMATIN BIOSCIENCE LTD
Jan 06, 2026, 08:00 ET Rimes Strengthens Leadership Team with Appointment of Former Snowflake and FactSet Executive Kieran Kennedy as Chief Revenue Officer
as one of the only firms with the breadth and depth of data intelligence needed to deliver on this transformation at scale.""Kieran brings a rare combination of financial data mastery, cloud platform expertise, and the proven ability to scale globally," said Vijay Mayadas, President & CEO
More news about: Rimes
Jan 06, 2026, 08:00 ET Rimes Strengthens Leadership Team with Appointment of Former Snowflake and FactSet Executive Kieran Kennedy as Chief Revenue Officer
as one of the only firms with the breadth and depth of data intelligence needed to deliver on this transformation at scale.""Kieran brings a rare combination of financial data mastery, cloud platform expertise, and the proven ability to scale globally," said Vijay Mayadas, President & CEO
More news about: Rimes